NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a company "Advancing Drugs Through Glycoscience®", today reported that a series of first-in-class, novel carbohydrate compounds significantly reduced collagen expression and reversed fibrosis in animal models. The data is scheduled to be presented at the Glycobiology 2007 Conference to be held at the Park Plaza Hotel, Boston, Mass., November 11-14.
